EPIDEMIOLOGICAL ASPECTS OF HIV-TB CO-INFECTION IN PEOPLE WITH HIV/AIDS (PLWHA): A HOSPITAL-BASED STUDY
Introduction : Tuberculosis (TB) is one of the co-infections with high morbidity and mortality in patients with HIV/AIDS (PLWHA). The prevalence of Tuberculosis in HIV patients in Indonesia ranges from 19.7% to 61.5%. Aims: This study aimed to identify predictors of incident HIV-TB co-infection in PLWHA. Methods: This observational study used a case-control design. Cases were defined as patients with HIV/AIDS co-infected with TB, while controls were those with HIV/AIDS without TB co-infection. The study population included 180 PLWHA, comprising 60 cases and 120 controls. Exclusion criteria for the case group were patients who had not completed their medical records and those who were previously infected with TB before HIV infection. Results: Bivariate analysis showed that variables significantly related to TB-HIV were clinical stage, CD4 levels, anemia status, and opportunistic infections. Multivariate logistic regression analysis showed that CD4 levels were the dominant predictor, with an adjusted odds ratio (AOR) of 5.71, 95% confidence interval (CI) 2.84-11.84, p = 0.0001. Meanwhile, clinical stage, anemia status, and opportunistic infections were confounding variables. Conclusion: CD4 levels were found to be a dominant predictor of increased TB-HIV risk. Further efforts should be made to encourage home assistant care initiation and improve medication compliance based on these results.
Abioye, A.I., Andersen, C. T., Sudfeld, C. R. and Fawzi, W. (2020). ‘Anemia, Iron Status, and HIV: A Systematic Review of the Evidence’, Advances in Nutrition, 11(5), pp. 1334–1363. https://doi.org/10.1093/advances/nmaa037
Ageru, T.A., Koyra, M. M., Gidebo, K. D. and Abiso, T. L.(2019). ‘Anemia and its associated factors among adult people living with human immunodeficiency virus at Wolaita Sodo University teaching referral hospital’, PloS One, 14(10), p. e0221853. https://doi.org/10.1371/journal.pone.0221853
Alene, K.A., Clements, A. C. A., McBryde, E. S., Jaramillo, E., Lönnroth, K., Shaweno, D., Gulliver, A. and Viney, K. (2018). ‘Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis’, Journal of Infection, 77(5), pp. 357–367. https://doi.org/10.1016/j.jinf.2018.07.007
Bruchfeld, J., Correia-Neves, M. and Källenius, G. (2015). Tuberculosis and HIV coinfection’, Cold Spring Harbor Perspectives in Medicine, 5(7), p. a017871. https://doi.org/10.1101/cshperspect.a017871
Castro, K.G. and Colvin, C.E. (2018) ‘Updated global tuberculosis targets: a welcome ambition in need of attention to quality of care’. https://doi.org/10.5588/ijtld.18.0344
Chanie, E. S., Feleke, D. G., Asnakew, S., GebreEyesus, F. A., Tesfaw, A., Bayih, W. A., Tigabu, A., Anyalem, Y. A., Amare, A. T., Belay, D. M., Dagnaw, F. T. and Abate, B. B. (2021). ‘Time to detection of anemia and its predictors among children living with HIV at Debre Tabor and University of Gondar Compressive Specialized Hospitals, 2020: a multicentre retrospective follow-up study’, BMC Pediatrics, 21(1), p. 151. https://doi.org/10.1186/s12887-021-02616-0
Dhurve, S.A. and Dhurve, A.S. (2013). ‘Bone marrow abnormalities in HIV disease’, Mediterranean Journal of Hematology and Infectious Diseases, 5(1). https://doi.org/10.4084/mjhid.2013.033
Drain, P. K., Losina, E., Parker, G., Giddy, J., Ross, D., Katz, J. N., Coleman, S. M., Bogart, L. M., Freedberg, K. A., Walensky, R. P. and Bassett, I. V. (2013). ‘Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa’, PloS One, 8(1), p. e55305. https://doi.org/10.1371/journal.pone.0055305
GBD 2019 Tuberculosis Collaborators. (2021). ‘Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019’, The Lancet Infectious Diseases, 22(2), pp.222-241
Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S. S., Anderson, M., McCauley, M., Gamble, T., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Pilotto, J. H., Godbole, S. V., Chariyalertsak, S., de Melo, M. G., Mayer, K. H., Eshleman, S. H., Piwowar-Manning, E., Makhemam J., Millsm L,A,, Panchiam R,, Sannem I,, Gallantm J,, Hoffman, I,, Taha, T.E., Nielsen-Saines, K., Celentano, D., Essex, M., Havlir, D., Cohen, M.S. and ,HPTN 052-ACTG Study Team (2014). ‘Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial’, The Lancet infectious diseases, 14(4), pp. 281–290. https://doi.org/10.1016/S1473-3099(13)70692-3
Haddad, N., Robert, A., Weeks, A., Popovic, N., Siu, W.and Archibald, C. (2019). (2019) ‘HIV: HIV in Canada—Surveillance report, 2018’, Canada Communicable Disease Report, 45(12), p. 304. https://doi.org/10.14745/ccdr.v45i12a01
Kamath, R., Sharma, V., Pattanshetty, S., Hegde, M. B. and Chandrasekaran, V. (2013). ‘HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India’, Lung India : official organ of Indian Chest Society, 30(4), pp. 302–306. doi:10.4103/0970-2113.120605. https://doi.org/10.4103/0970-2113.120605
Kaplan, R., Hermans, S., Caldwell, J., Jennings, K., Bekker, L. G.and Wood, R. (2018). ‘HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town’, BMC Infectious Diseases, 18(1), p. 356. https://doi.org/10.1186/s12879-018-3256-9
Lemeshow, S. and Lwanga, S.K. (1991). Sample Size Determination in Health Studies. World Health Organization.
Li, L., Abudureheman, Z., Zhong, X., Gong, H., Yang, F., Awuti, A., Alimu, A., Yilamujiang, S., Zheng, D. and Zou, X. (2023). ‘Clinical symptoms and immune injury reflected by low CD4/CD8 ratio should increase the suspicion of HIV coinfection with tuberculosis’, Heliyon, p. e14219. https://doi.org/10.1016/j.heliyon.2023.e14219
Li, Z., Jin, Y. and Li, P. (2017). ‘Prevalence and influencing factors of anemia in elderly patients with HIV/AIDS’, China Journal of Dermatovenereology, 31(4), pp. 442–444.
Maartens, G., Celum, C. and Lewin, S.R. (2014). ‘HIV infection: epidemiology, pathogenesis, treatment, and prevention’, The Lancet, 384(9939), pp. 258–271.
Mahmud, S., Mohsin, M., Muyeed, A., Islam, M. M., Hossain, S. and Islam, A. (2023). ‘Prevalence of HIV and syphilis and their co-infection among men having sex with men in Asia: A systematic review and meta-analysis’, Heliyon, 9(3), p. e13947. https://doi.org/10.1016/j.heliyon.2023.e13947
Maore, N.K., Kirui, N.K., Ogutu, O., Owino, M., Ogaro, T., Mueni, E., Mulonzi, M., Louis, J.C., Japhet, C., Kimenye, K., Omesa, E., Masini, E., Wekunda, P.W. and Ng’ang’a, M.(2017). ‘Spatial and temporal distribution of notified tuberculosis cases in Nairobi County, Kenya, between 2012 and 2016’, East African Medical Journal, 94(10), pp. S28–S40.
Marchionatti, A. and Parisi, M.M. (2021). ‘Anemia and thrombocytopenia in people living with HIV/AIDS: a narrative literature review’, International Health, 13(2), pp. 98–109. https://doi.org/10.1093/inthealth/ihaa036
Mattingly, T.J., Pandit, N.S. and Onukwugha, E. (2019). ‘Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population’, Infectious Diseases and Therapy, 8(2), pp. 219–228. https://doi.org/10.1007/s40121-019-0240-7
Ministry of Health, (2015). Rencana Aksi Nasional Kolaborasi TB-HIV 2015-2019.
Petersdorf, N., Ross, J.M., Weiss, H.A., Barnabas, R.V., Wasserheit, J.N. and HCV and HIV Transmission Working Group. (2016) ‘Systematic review and meta-analysis of hepatitis C virus infection and HIV viral load: new insights into epidemiologic synergy’, Journal of the International AIDS Society, 19(1), p. 20944. https://doi.org/10.7448/IAS.19.1.20944
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, I., Razavi, H. and Vickerman, P. (2016). (2016). ‘Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis’, The Lancet infectious diseases, 16(7), pp. 797–808. https://doi.org/10.1016/S1473-3099(15)00485-5
Prezzemolo, T., Guggino, G., La Manna, M. P., Di Liberto, D., Dieli, F. and Caccamo, N. (2014). ‘Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis’, Frontiers in Immunology , 5, p. 180. Rockwood, N., Abdullahi, L. H., Wilkinson, R. J. and Meintjes, G. (2015). ‘Risk factors for acquired rifamycin and isoniazid resistance: a systematic review and meta-analysis’, PloS One, 10(9), p. e0139017. https://doi.org/10.3389/fimmu.2014.00180
Roselinda, V.S. (2015). ‘The stages of HIV Infection and the risk of opportunistic tuberculosis infection’, HIV and tuberculosis infection, 6(2), pp. 121–123. https://doi.org/10.22435/hsji.v6i2.4771.121-125
Sifuna, P. M., Ouma, C., Atieli, H., Owuoth, J., Onyango, D., Andagalu, B. and Cowden, J. (2019). ‘Spatial epidemiology of tuberculosis in the high-burden counties of Kisumu and Siaya, Western Kenya, 2012–2015’, The International Journal of Tuberculosis and Lung Disease, 23(3), pp. 363–370.
Singh, K. P., Crane, M., Audsley, J., Avihingsanon, A., Sasadeusz, J. and Lewin, S. R. (2017). ‘HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment’, AIDS (London, England), 31(15), p. 2035. https://doi.org/10.5588/ijtld.18.0245
Sitorus, R.J., Anwar, C., Purba, I, and Natalia, M. (2021). ‘Determinan Kadar Cluster Diferensiasi 4 (CD4) pada Orang dengan HIV/AIDS’, Jurnal Kesehatan; 12( 1). https://doi.org/10.26630/jk.v12i1.2423
Stover, J., Glaubius, R., Kassanjee, R. and Dugdale, C. M. (2021). ‘Updates to the Spectrum/AIM model for the UNAIDS 2020 HIV estimates’, Journal of the International AIDS Society, 24, p. e25778. https://doi.org/10.1002/jia2.25778
Teklu, A. M., Nega, A., Mamuye, A. T., Sitotaw, Y., Kassa, D., Mesfin, G., Belayihun, B., Medhin, G. and Yirdaw, K. (2017). ‘Factors associated with mortality of TB/HIV co-infected patients in Ethiopia’, Ethiopian Journal of Health Sciences, 27(1), pp. 29–38. https://doi.org/10.4314/ejhs.v27i1.4S
Ulrich, A. K., Adamson, B. J., Saldarriaga, E. M., Grecca, R., Wood, D., Babigumira, J. B., Sanchez, J. L., Lama, J. R., Dimitrov, D. and Duerr, A. (2022). ‘Finding and treating early-stage HIV infections: A cost-effectiveness analysis of the Sabes study in Lima, Peru’, The Lancet Regional Health - Americas, 12, p. 100281. https://doi.org/10.1016/j.lana.2022.100281
United Nations (2014) ‘Fast-track: ending the AIDS epidemic by 2030’, Geneva: UNAIDS [Preprint].
WHO (2005) Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance: African Region. Geneva:World Health Organization.
WHO. (2016). ‘Daily iron supplementation in infants and children’. Geneva: World Health Organization [Preprint].
WHO (2019). Global tuberculosis report 2019. Geneva: World Health Organization.
WHO (2020) ‘Global Tuberculosis Report 2020’. Geneva: World Health Organization.
Zaongo, S. D., Ouyang, J., Chen, Y., Jiao, Y. M., Wu, H. and Chen, Y. (2022). ‘HIV Infection predisposes to increased chances of HBV infection: current understanding of the mechanisms favoring HBV infection at each clinical stage of HIV infection’, Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.853346
Copyright (c) 2024 The Indonesian Journal of Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The authors agree to transfer the transfer copyright of the article to The Indonesian Journal of Public Health effective if and when the paper is accepted for publication.
- Authors and other parties are bound to the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License for the published articles, legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA), implies that:
- Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial ” You may not use the material for commercial purposes.
- ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
